197 related articles for article (PubMed ID: 19254954)
1. Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor.
Okamura T; Singh S; Buolamwini J; Haystead T; Friedman H; Bigner D; Ali-Osman F
J Biol Chem; 2009 Jun; 284(25):16979-16989. PubMed ID: 19254954
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells.
Okamura T; Antoun G; Keir ST; Friedman H; Bigner DD; Ali-Osman F
J Biol Chem; 2015 Dec; 290(52):30866-78. PubMed ID: 26429914
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models.
Formisano L; Nappi L; Rosa R; Marciano R; D'Amato C; D'Amato V; Damiano V; Raimondo L; Iommelli F; Scorziello A; Troncone G; Veneziani B; Parsons SJ; De Placido S; Bianco R
Breast Cancer Res; 2014 May; 16(3):R45. PubMed ID: 24887236
[TBL] [Abstract][Full Text] [Related]
4. Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCα enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells.
Singh S; Okamura T; Ali-Osman F
Biochem Pharmacol; 2010 Nov; 80(9):1343-55. PubMed ID: 20654585
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene.
Lo HW; Stephenson L; Cao X; Milas M; Pollock R; Ali-Osman F
Mol Cancer Res; 2008 May; 6(5):843-50. PubMed ID: 18505928
[TBL] [Abstract][Full Text] [Related]
6. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice.
Lee SY; Meier R; Furuta S; Lenburg ME; Kenny PA; Xu R; Bissell MJ
J Clin Invest; 2012 Sep; 122(9):3211-20. PubMed ID: 22886303
[TBL] [Abstract][Full Text] [Related]
7. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
8. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.
Zhou H; Kim YS; Peletier A; McCall W; Earp HS; Sartor CI
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):344-52. PubMed ID: 14751502
[TBL] [Abstract][Full Text] [Related]
9. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
[TBL] [Abstract][Full Text] [Related]
10. Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.
Koumangoye RB; Nangami GN; Thompson PD; Agboto VK; Ochieng J; Sakwe AM
Mol Cancer; 2013 Dec; 12(1):167. PubMed ID: 24354805
[TBL] [Abstract][Full Text] [Related]
11. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.
Diaz R; Nguewa PA; Parrondo R; Perez-Stable C; Manrique I; Redrado M; Catena R; Collantes M; Peñuelas I; Díaz-González JA; Calvo A
BMC Cancer; 2010 May; 10():188. PubMed ID: 20459769
[TBL] [Abstract][Full Text] [Related]
13. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.
Peklak-Scott C; Smitherman PK; Townsend AJ; Morrow CS
Mol Cancer Ther; 2008 Oct; 7(10):3247-55. PubMed ID: 18852128
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferases P1-mediated interleukin-6 in tumor-associated macrophages augments drug-resistance in MCF-7 breast cancer.
Dong X; Sun R; Wang J; Yu S; Cui J; Guo Z; Pan X; Sun J; Yang J; Pan LL
Biochem Pharmacol; 2020 Dec; 182():114289. PubMed ID: 33080187
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.
Sawers L; Ferguson MJ; Ihrig BR; Young HC; Chakravarty P; Wolf CR; Smith G
Br J Cancer; 2014 Sep; 111(6):1150-8. PubMed ID: 25010864
[TBL] [Abstract][Full Text] [Related]
16. Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells.
Zhang D; Pal A; Bornmann WG; Yamasaki F; Esteva FJ; Hortobagyi GN; Bartholomeusz C; Ueno NT
Mol Cancer Ther; 2008 Jul; 7(7):1846-50. PubMed ID: 18644997
[TBL] [Abstract][Full Text] [Related]
17. Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways.
Imami K; Sugiyama N; Imamura H; Wakabayashi M; Tomita M; Taniguchi M; Ueno T; Toi M; Ishihama Y
Mol Cell Proteomics; 2012 Dec; 11(12):1741-57. PubMed ID: 22964224
[TBL] [Abstract][Full Text] [Related]
18. A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.
Wood ER; Truesdale AT; McDonald OB; Yuan D; Hassell A; Dickerson SH; Ellis B; Pennisi C; Horne E; Lackey K; Alligood KJ; Rusnak DW; Gilmer TM; Shewchuk L
Cancer Res; 2004 Sep; 64(18):6652-9. PubMed ID: 15374980
[TBL] [Abstract][Full Text] [Related]
19. EGFR inhibitor enhances cisplatin sensitivity of human glioma cells.
Zhang Y; Xing X; Zhan H; Li Q; Fan Y; Zhan L; Yu Q; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):773-778. PubMed ID: 22173497
[TBL] [Abstract][Full Text] [Related]
20. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
Mueller KL; Hunter LA; Ethier SP; Boerner JL
Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
